Company / Working Capital per Share
Akebia Therapeutics, Inc. Working Capital per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.40
FY2025
5-year range
$0.10 / $0.40
FY2021-FY2025
Trend
+136.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has fluctuated over the past 10 years, ranging from $0.10 in FY2023 to $74.89 in FY2014.
Based on SEC 10-K filings.
0.40 in FY2025 with a 10-year CAGR of -24.1%.
Improved from $0.10 to $0.40 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +8.4%
- 5-Year CAGR
- -23.4%
- 10-Year CAGR
- -24.1%
Key checks
Key Insights
- In FY2025, working capital per share increased 136.7% year-over-year.
- Peak working capital per share was recorded in FY2014.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.40 | +136.7% |
| FY2024 | $0.17 | +70.4% |
| FY2023 | $0.10 | -68.4% |
| FY2022 | $0.31 | +200.0% |
| FY2021 | $0.10 | -93.1% |
| FY2020 | $1.51 | +74.6% |
| FY2019 | $0.87 | -79.6% |
| FY2018 | $4.25 | -32.9% |
| FY2015 | $6.34 | -91.5% |
| FY2014 | $74.89 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026